Literature DB >> 2963023

Lyme disease. A neuro-ophthalmologic view.

A B MacDonald1.   

Abstract

Lyme borreliosis is a spirochetal infection with a potential to produce a clinical disease in the human host with protean manifestations as diverse as the spectrum of disease caused by Treponema pallidum. Neuro-ophthalmologic manifestations of Lyme borreliosis are emphasized in this short review. A brief historical chronicle of Lyme disease is offered. Potential pitfalls in the diagnosis of Lyme disease with an emphasis on false negative serology and currently available diagnostic modalities are presented. Therapeutic options for Lyme borreliosis are briefly reviewed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2963023     DOI: 10.3109/01658108709007451

Source DB:  PubMed          Journal:  J Clin Neuroophthalmol        ISSN: 0272-846X


  6 in total

1.  Persistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human Lyme disease.

Authors:  V Preac Mursic; E Patsouris; B Wilske; S Reinhardt; B Gross; P Mehraein
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

2.  Unusual neurological manifestations of Lyme disease: a case report.

Authors:  M Del Sette; C Caponnetto; D Fumarola; G L Mancardi
Journal:  Ital J Neurol Sci       Date:  1989-08

3.  Neuro-ophthalmological manifestations of tick-borne borreliosis: a case report.

Authors:  K Albermann; W Blunck; H Helwig
Journal:  Eur J Pediatr       Date:  1993-12       Impact factor: 3.183

4.  Lyme disease. First reported case in Sicily.

Authors:  R Rinaldi; A S Gabellini; L Procaccio; G Benassi; R D'Alessandro
Journal:  Ital J Neurol Sci       Date:  1991-02

Review 5.  Lyme borreliosis: ten years after discovery of the etiologic agent, Borrelia burgdorferi.

Authors:  W Burgdorfer
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

6.  Active immunization with pC protein of Borrelia burgdorferi protects gerbils against B. burgdorferi infection.

Authors:  V Preac-Mursic; B Wilske; E Patsouris; S Jauris; G Will; E Soutschek; S Rainhardt; G Lehnert; U Klockmann; P Mehraein
Journal:  Infection       Date:  1992 Nov-Dec       Impact factor: 3.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.